134 related articles for article (PubMed ID: 2534343)
1. Serum CA-125 levels in women with endometriosis.
Fraser IS; McCarron G; Markham R
Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):416-20. PubMed ID: 2534343
[TBL] [Abstract][Full Text] [Related]
2. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
[TBL] [Abstract][Full Text] [Related]
3. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
Fraser IS; Shearman RP; Jansen RP; Sutherland PD
Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
[TBL] [Abstract][Full Text] [Related]
4. CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists.
Acien P; Shaw RW; Irvine L; Burford G; Gardner R
Eur J Obstet Gynecol Reprod Biol; 1989 Sep; 32(3):241-6. PubMed ID: 2676640
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of endometriosis.
Saltiel E; Garabedian-Ruffalo SM
Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
Burry KA; Patton PE; Illingworth DR
Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
[TBL] [Abstract][Full Text] [Related]
8. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
[TBL] [Abstract][Full Text] [Related]
9. Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis.
Letassy NA; Thompson DF; Britton ML; Suda RR
DICP; 1990 Dec; 24(12):1204-9. PubMed ID: 2151003
[TBL] [Abstract][Full Text] [Related]
10. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
[TBL] [Abstract][Full Text] [Related]
11. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
[TBL] [Abstract][Full Text] [Related]
12. Nafarelin versus danazol in the treatment of endometriosis.
Rolland R; van der Heijden PF
Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
[TBL] [Abstract][Full Text] [Related]
13. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
Kennedy SH; Starkey PM; Sargent IL; Hicks BR; Barlow DH
Obstet Gynecol; 1990 Jun; 75(6):914-8. PubMed ID: 2140439
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of nafarelin in the treatment of endometriosis.
Henzl MR; Kwei L
Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
[TBL] [Abstract][Full Text] [Related]
15. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
Ylikorkala O; Nilsson CG; Hirvonen E; Viinikka L
Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
[TBL] [Abstract][Full Text] [Related]
16. Nafarelin in the treatment of pelvic pain caused by endometriosis.
Shaw RW
Am J Obstet Gynecol; 1990 Feb; 162(2):574-6. PubMed ID: 2137972
[TBL] [Abstract][Full Text] [Related]
17. A comparison of nafarelin acetate and danazol in the treatment of endometriosis.
Kennedy SH; Williams IA; Brodribb J; Barlow DH; Shaw RW
Fertil Steril; 1990 Jun; 53(6):998-1003. PubMed ID: 2140996
[TBL] [Abstract][Full Text] [Related]
18. CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence.
Nagamani M; Kelver ME; Smith ER
Int J Fertil; 1992; 37(4):227-31. PubMed ID: 1354210
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
Välimäki M; Nilsson CG; Roine R; Ylikorkala O
J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
[TBL] [Abstract][Full Text] [Related]
20. A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan.
Cheng MH; Yu BK; Chang SP; Wang PH
J Chin Med Assoc; 2005 Jul; 68(7):307-14. PubMed ID: 16038370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
